AlphaCentric Advisors LLC - AERIE PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
AlphaCentric Advisors LLC ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$962,000
+77.5%
137,000
+188.4%
0.28%
+102.9%
Q3 2021$542,000
+903.7%
47,500
+1087.5%
0.14%
+500.0%
Q4 2020$54,000
+5300.0%
4,000
+3900.0%
0.02%
Q3 2020$1,0001000.00%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 805,217$14,212,0004.99%
DAFNA Capital Management LLC 156,842$2,768,0002.34%
NORTHPOINTE CAPITAL LLC 1,034,400$18,257,0002.15%
HARVEY CAPITAL MANAGEMENT INC 223,200$3,856,0001.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,211,644$39,036,0001.30%
Boulegeris Investments, Inc. 88,660$1,565,0001.12%
Partner Investment Management, L.P. 43,623$770,0001.08%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 150,000$2,648,0000.92%
PFM Health Sciences, LP 1,851,564$32,680,0000.83%
Benchmark Capital Advisors 55,400$978,0000.69%
View complete list of AERIE PHARMACEUTICALS INC shareholders